NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs, today announced the filing of two U.S. provisional patent applications that significantly expand the Company's...
Hence then, the article about hoth therapeutics expands oncology pipeline with dual patent filings establishing novel oncology dermatology ip platform was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform )
Also on site :
- Atalanta vs Parma: How to Watch Live, Match Time and TV Channels
- Transamerica Institute’s CEO warns of a retirement ‘perfect storm’ as even affluent Americans fall short of the $2.6 million goal
- In the 1950s, Roger Baillon began collecting vintage cars that rusted in sheds for decades; they sold for 25 million euros in 2015